Fermenta Biotech Limited receives EU GMP Certification for its Dahej Manufacturing Facility, Gujarat, India.

▴ Fermenta Biotech Limited
The certificate of GMP compliance underscores our commitment to global standards of quality, compliance and consistency in manufacturing.

Dahej, 19th September 2024 :Fermenta Biotech Limited’s Active Pharmaceutical Ingredient (API) manufacturing facility situated at Dahej, Gujarat, India has received a certificate of GMP compliance from the Competent Authority of Germany, following a European Union Good Manufacturing Practice (EU GMP) inspection that was conducted in March 2024. This approval reflects Company’s unwavering commitment that the Quality Assurance is in compliance with the stringent guidelines of Good Manufacturing Practices.

Mr. Prashant Nagre, Managing Director of Fermenta, commented on the occasion, “We are pleased with the positive outcome of the recent EU GMP inspection at our Dahej Manufacturing Facility in Gujarat. The certificate of GMP compliance underscores our commitment to global standards of quality, compliance and consistency in manufacturing.”

 

About Fermenta Biotech Limited (FBL):

Founded in 1951, Fermenta Biotech Limited (FBL) possesses a growing portfolio of nutrition including Customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, FBL is the only manufacturer of Vitamin D3 in India and a leading global player. It caters to over 350 customers across 60 countries with a worldwide distribution network for a variety of applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition and rodenticides. FBL's manufacturing facilities in Kullu and Dahej are certificated by global accreditations and its world class R&D centre is located at Thane. FBL also possesses expertise in integrated biotechnology such as enzymes for antibiotic synthesis, other niche APIs and environmental solutions.

For more information about the Company and its businesses, please visit our website www.fermentabiotech.com

 

 

Safe Harbor :

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or other factors.

 

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026